Advertisement
Financing › Details
Genoptix–Novartis: investment, 201701–201703 DIVESTMENT sale €na of Genoptix (excl biopharma business) to Ampersand + 1315 Capital + new managers
Period | 2011-01-24 | |
Money taker | Genoptix Inc. | |
Money source | Novartis AG (NYSE: NVS) | |
Group | Novartis (Group) | |
Product | diagnostic services | |
Product 2 | pharmacodiagnostic test (PDx) | |
Person | Limber, Joseph M. (Prometheus Laboratories 200711 CEO) | |
Person 2 | Spring, Mark (Genoptix 201703– CFO before Prometheus Laboratories) | |
Source | – [GenomeWeb]. (3/7/17). "News: Novartis Completes Sale of Genoptix Lab Business". New York, NY. | |
Record changed: 2017-03-15 |
Advertisement
More documents for Genoptix Inc.
- [1] – [GenomeWeb]. (3/7/17). "News: Novartis Completes Sale of Genoptix Lab Business". New York, NY....
- [2] – [GenomeWeb]. (1/30/17). "News: Novartis to Sell Genoptix Lab Business to Investment Group". New York, NY....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top